Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Metformin hydrochloride may stop the growth of tumor cells by blocking some of the
enzymes needed for cell growth.
PURPOSE: This phase I trial is studying how well metformin hydrochloride works in treating
women with stage I or stage II breast cancer that can be removed by surgery.